TP53 and cancer: Supplementary Fig. 5 highlights significantly enriched pathways, including MYC targets, DNA repair, G2M checkpoint, p53 and cancer-related pathways in SV-iPS cells, while Epi-iPS cells showed enrichment in a few pathways including hypoxia and glycolysis.